|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Department of Pharmaceutical/Medicinal Chemistry I, School of Pharmacy, University of Regensburg, Regensburg, Germany (A.S., B.S.); Faculty of Chemistry and Pharmacy, University of Regensburg, Regensburg, Germany (H.-J.W.); and Department of Pharmacology and Toxicology, School of Pharmacy, University of Regensburg, Regensburg, Germany (R.S.)
There are differences in the pharmacological properties of phenylhistamines and histaprodifens between guinea pig histamine H1 receptor (gpH1R) and human histamine H1 receptor (hH1R). The aim of this study was to analyze species differences in more detail, focusing on histaprodifen derivatives and including the bovine histamine H1 receptor (bH1R) and rat histamine H1 receptor (rH1R). H1R species isoforms were coexpressed with the regulator of G protein signaling RGS4 in Sf9 insect cells. We performed [3H]mepyramine binding assays and steady-state GTPase assays. For a novel class of histaprodifens, the chiral histaprodifens, unique species differences between hH1R, bH1R, rH1R, and gpH1R were observed. The chiral histaprodifens 8R and 8S were both partial agonists at gpH1R, but only 8R was a partial agonist at the other H1R species isoforms. An additional phenyl group in chiral histaprodifens 10R and 10S, respectively, resulted in a switch from agonism at gpH1Rto antagonism at hH1R, bH1R, and rH1R. In general, histaprodifens showed the order of potency hH1R < bH1R < rH1R < gpH1R. An active-state model of gpH1R was generated with molecular dynamics simulations. Dimeric histaprodifen was docked into the binding pocket of gpH1R. Hydrogen bonds and electrostatic interactions were detected between dimeric histaprodifen and Asp-116, Ser-120, Lys-187, Glu-190, and Tyr-432. We conclude the following: 1) chiral histaprodifens interact differentially with H1R species isoforms; 2) gpH1R and rH1R, on one hand, and hH1R and bH1R, on the other hand, resemble each other structurally and pharmacologically; and 3) histaprodifens interact with H1R at multiple sites.
Address correspondence to: Dr. Roland Seifert, Department of Pharmacology and Toxicology, University of Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany. E-mail: roland.seifert{at}chemie.uni-regensburg.de
This article has been cited by other articles:
![]() |
K.-F. Deml, S. Beermann, D. Neumann, A. Strasser, and R. Seifert Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor Mol. Pharmacol., November 1, 2009; 76(5): 1019 - 1030. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Wittmann, R. Seifert, and A. Strasser Contribution of Binding Enthalpy and Entropy to Affinity of Antagonist and Agonist Binding at Human and Guinea Pig Histamine H1-Receptor Mol. Pharmacol., July 1, 2009; 76(1): 25 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strasser, H.-J. Wittmann, M. Kunze, S. Elz, and R. Seifert Molecular Basis for the Selective Interaction of Synthetic Agonists with the Human Histamine H1-Receptor Compared with the Guinea Pig H1-Receptor Mol. Pharmacol., March 1, 2009; 75(3): 454 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seifert and S. Dove Functional Selectivity of GPCR Ligand Stereoisomers: New Pharmacological Opportunities Mol. Pharmacol., January 1, 2009; 75(1): 13 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strasser, H.-J. Wittmann, and R. Seifert Ligand-Specific Contribution of the N Terminus and E2-Loop to Pharmacological Properties of the Histamine H1-Receptor J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 783 - 791. [Abstract] [Full Text] [PDF] |
||||